Tag: subarachnoid haemorrhage

CereVasc announces US FDA approval for second IDE study of eShunt...

CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...

Current literature suggests promise held by electrical stimulation therapies for cerebral...

Electrical stimulation technologies, and in particular spinal cord stimulation (SCS) and sphenopalatine ganglion stimulation, offer a promising adjunct to existing therapies for cerebral vasospasm...